Cytogenetic abnormalities without evidence of relapse after treatment with imatinib and stem cell transplantation in a patient with Ph-positive ALL.
Sakai
Miwa
M
Ohashi
Kazuteru
K
Kobayashi
Takeshi
T
Yamashita
Takuya
T
Akiyama
Hideki
H
Sakamaki
Hisashi
H
D001549:Benzamides; D002869:Chromosome Aberrations / Q000139:chemically induced*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects* / Q000379:methods; D006801:Humans; D000068877:Imatinib Mesylate; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy*; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use; D012074:Remission Induction / Q000379:methods; D018183:Transplantation Chimera
D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate